课题基金 / 基金详情

ROLE OF RHO IN FARNESYLTRANSFERASE INHIBITOR RESPONSES

ROLE OF RHO IN FARNESYLTRANSFERASE INHIBITOR RESPONSES
RHO 在法呢基转移酶抑制剂反应中的作用
批准号:
6173589
负责人:
GEORGE C PRENDERGAST
金额:
$17.02万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-09-30 至 2004-07-31

项目摘要

项目成果

GEORGE C PRENDERGAST的其他基金

相似基金

相关文献

中文摘要
翻译
在旨在阻断癌细胞信号转导的临床试验中,法尼基转移酶抑制剂(FTI)是首批“设计药物”之一。FTI被用来攻击含有致癌RAS的肿瘤,其功能依赖于翻译后法尼化。临床前试验已经证明了FTI对恶性转化细胞的显著特异性作用。然而,机械性的调查提出了怀疑,认为RAS是药物抑制的必要靶点。因此,除了RAS以外的FTI靶蛋白的作用机制和识别已经成为重要的问题。指导性假设和具体目标。我们建议检验FTI部分通过改变Rho苯基化和功能发挥作用的假说(“FTI-Rho假说”)。初步研究促使RhoB成为一种研究范式。与FTI反应和Rho改变相关的细胞黏附和基因激活事件将被调查。通过FTI区分细胞凋亡和细胞生长抑制的机制将被定义。简而言之,我们的目标是1)建立Rho作为FTI的靶标,2)确定介导FTI反应所需的Rho依赖的事件,3)确定决定生长抑制和细胞凋亡的因素。创新和意义。我们提案中的主要创新元素是将智力焦点从RAS转移到RHO,作为一个领域来了解癌细胞中FTI的作用机制。定义FTI机制(S)将促进临床应用以及对癌细胞病理生理学的新见解。
英文摘要
Farnesyltransferase inhibitors (FTIs) are among the first 'designer drugs' in clinical trials aimed at blocking cancer cell signal transduction. FTIs were made to attack tumors containing oncogenic Ras, whose function depends upon posttranslational farnesylation. Preclinical trials have demonstrated strikingly specific effects of FTIs against malignantly transformed cells. However, mechanistic investigations have raised doubts that Ras is a necessary target for drug inhibition. Thus, the mechanism of action and identity of FTI target proteins other than Ras have emerged as important questions. Guiding Hypothesis and Specific Aims. We propose to test the hypothesis that FTIs act in part through alteration of Rho prenylation and function (the 'FTI-Rho hypothesis'). Preliminary studies prompt RhoB as a paradigm for study. Cell adhesion and gene activation events related to FTI response and Rho alteration will be investigated. Mechanisms that distinguish apoptosis and cell growth inhibition by FTIs will be defined. In short, we aim to 1) establish Rho as an FTI target, 2) identify Rho-dependent events required to mediate FTI response, and 3) define the factors that dictate growth inhibition versus apoptosis. Innovation and Significance. The main element of innovation in our proposal is the shift of intellectual focus from Ras to Rho as a realm to understand the mechanism of FTI action in cancer cells. Defining FTI mechanism(s) will promote clinical applications as well as novel insights into cancer cell pathophysiology.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Probing an Unexplored Intracellular Pathway in Diabetes Pathogenesis
Probing an Unexplored Intracellular Pathway in Diabetes Pathogenesis
IDO2 Targeting in Pancreatic Cancer
OPPC targeting to improve pancreatic cancer treatment
国内基金
海外基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    郑绪阳
  • 依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2017
  • 负责人:
    卫高菲
  • 依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2016
  • 负责人:
    陈昊
  • 依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 项目类别:
    面上项目
  • 资助金额:
    73.0万元
  • 批准年份:
    2014
  • 负责人:
    董家鸿
  • 依托单位: